Skip to content
Home/Companies/Biotech/GAMUT Therapeutics
GT

GAMUT Therapeutics

Biotech·France·Exited 2021·Held 1yr

GAMUT Therapeutics is a biotech company, headquartered in France.

Entry
2020
Hold
1yr
Exit
2021
Est. EV
–

Who owns GAMUT Therapeutics?

GAMUT Therapeutics was owned by AdBio Partners through AFB Seed-Fund (2017 vintage) from 2020 to 2021, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-07

AdBio Partners
Investor
AdBio Partners
AFB Seed-Fund · 2017 · VC

Key facts

HQFrance
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2021

More from AFB Seed-Fund

Other portfolio companies in the same fund.

Alderaan Biotechnology
Active
HealthcareFrance· 2020
ARTHEx Biotech
Active
HealthcareSpain· 2020
Kalsiom
Active
HealthcareFrance· 2020
Wellium
Active
HealthcareFrance· 2020
Agomab Therapeutics
Exited 2026
HealthcareBelgium· 2019
to
SparingVision
Active
HealthcareFrance· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
2NA FISH
Active
Gruenderfonds RuhrGermany· 2026
Data refreshed weekly · Sourced from public filings